New “fusion sites” enable faster and more targeted drug development

Many important medicines, such as antibiotics and anticancer drugs, are derived from natural products from Bacteria.

XtalPi’s AI biologics discovery platform licensed to Janssen

The non-exclusive licence will enable Janssen to utilise Xtalpi’s proprietary AI biologics discovery platform. Credit: Premreuthai/Shutterstock. XtalPi, an AI drug discovery company and subsidiary of

October 11, 2024

Uveitis drugs in development, 2023

GlobalData tracks 85 drugs in development for Uveitis by 77 companies/universities/institutes. The top development phase for Uveitis is preclinical, with 51 drugs in that stage.

December 1, 2023

Cellectis to focus on CAR-T cell therapies in 2023 – Pharmaceutical Technology

Cellectis reported having $89m in cash reserves as of 30 June 2023, compared to $95m cash reserves on 31 December 2022. Image Credit: Alpha Tauri

August 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.